Loading viewer...
report
Format: PDF report
This report presents the top-line results of Zogenix's Phase 3 Study 1504, highlighting the efficacy of ZX008 for treating seizures in Dravet syndrome.
Zogenix Q4 2016 Financial Results Earnings Presentation
earningsearnings
20 Pages
report
ArcGIS
report
General Atlantic
report
SOS International
report
udaan